Alnylam Pharmaceuticals, Inc.Cambridge, MA, United States (NASDAQ (GM): ALNY)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Alnylam Financial Market Data

Current Information
Last Close 01-Oct-2008 $27.72 Price/ Sales Ratio 14.80
52-Week High $37.35 Price/ Book Ratio 5.99
52-Week Low $22.25 Price/ Earnings Ratio --
60-Month Beta 1.6 Price/ Cash Flow Ratio 3.95
Market Cap (mil.) $1,139.1 Return on Assets (16.3%)
Shares Outstanding (mil.) 41.1 Return on Equity (34.4%)
Dividend Rate -- Current Ratio 5.21
Dividend Yield -- Long-Term Debt/Equity 0.02
# of Institutional Holders 135 % Owned by Institutions 70.0%
Latest Short Interest Ratio 9.87 Latest Net Insider Transactions 0.00

Growth Rates 12 Month 36 Month 60 Month
Revenue Growth 155.4% 1,091.2% 0.0%
EPS Growth 0.0% 0.0% 0.0%
Dividend Growth 0.0% 0.0% 0.0%
Edgar Online logo
This data is provided as per license from EDGAR Online